BiondVax should defend against highly pathogenic bird flu
Studies indicate Israeli universal flu vaccine candidate induces immune response against potential pandemic strains of avian influenza in Europe and Asia.
Studies indicate Israeli universal flu vaccine candidate induces immune response against potential pandemic strains of avian influenza in Europe and Asia.
Israeli company Biondvax has developed a flu vaccine that can be used to vaccinate against every type of flu, including deadly strains like bird and swine flu.
Israeli-made vaccine is suited to all six new and potentially pandemic flu strains — H5N1, H5N8, H6N1, H7N7, H7N9 and H10N8.
Israeli biotech company says its universal flu vaccine enhances the efficiency of the human pandemic bird flu inoculation.